Home/Pipeline/Breast Cancer Recurrence Research

Breast Cancer Recurrence Research

Breast Cancer Prognosis

ResearchActive

Key Facts

Indication
Breast Cancer Prognosis
Phase
Research
Status
Active
Company

About Qmetrics Technologies

Qmetrics Technologies operates at the intersection of digital health and AI, providing advanced medical image analysis services and software. Its core offerings include clinical trial imaging support through a centralized core lab and a proprietary platform, Kuvia3D, which transforms 2D MRI scans into quantifiable 3D models for applications in sports medicine, neurology, and oncology. The company combines decades of team expertise in musculoskeletal radiology and imaging science with AI-driven radiomics to detect subtle patterns invisible to conventional radiology, aiming to improve clinical trial efficiency and diagnostic insight. It serves as a specialized service provider to the life sciences industry while also developing its own diagnostic indices.

View full company profile

Other Breast Cancer Prognosis Drugs

DrugCompanyPhase
PCRchitectur-based Prognostic TestSignatur BiosciencesDevelopment